Ignite Creation Date:
2025-12-24 @ 2:13 PM
Ignite Modification Date:
2026-02-21 @ 11:18 PM
Study NCT ID:
NCT00540995
Status:
TERMINATED
Last Update Posted:
2023-11-30
First Post:
2007-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer
Sponsor:
City of Hope Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Adult Acute Myeloid Leukemia in Remission | View |
| None | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | View |
| None | Adult Acute Myeloid Leukemia With Del(5q) | View |
| None | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | View |
| None | Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) | View |
| None | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | View |
| None | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | View |
| None | Blastic Phase Chronic Myelogenous Leukemia | View |
| None | Childhood Acute Myeloid Leukemia in Remission | View |
| None | Childhood Chronic Myelogenous Leukemia | View |
| None | Childhood Myelodysplastic Syndromes | View |
| None | Previously Treated Myelodysplastic Syndromes | View |
| None | Recurrent Adult Acute Myeloid Leukemia | View |
| None | Recurrent Childhood Acute Myeloid Leukemia | View |
| None | Refractory Anemia With Excess Blasts | View |
Keywords: